Depression illnesses are brain disorders caused by genetic, biological, environmental, and psychological factors, and they produce emotional problems, sadness, hopelessness, anger, disinterest, loss of pleasure, sleep disturbances, energy loss, anxiety, changes in appetite, and the feeling of worthlessness. Currently, depression is treated with pharmaceutical medications or psychological counseling, but now medical cannabis is being analyzed as a potential treatment option because of its antidepressant and antipsychotic effects.
It's already well-known that the endocannabinoid system is linked to mood management, so many believe cannabinoids could play a role in regulating the endocannabinoid system and therefore stabilize a person's mood. Studies have confirmed this theory, and both THC and CBD have sedative, antidepressant, and antipsychotic effects. In an animal trial, cannabinoids restores endocannabinoid function and therefore stabilized mood and reduced depression. Other animal trials found CBD had anti-anxiety and antidepressant effects at a rapid rate, and evidence suggests it is thanks to CBD's interaction with the 5-HT1A neuro-receptor. A human study found people who used THC were less negative when processing their emotions, and both CBD and THC reduced a response to fearful faces.
This information has been provided by Medical Marijuana Inc. and approved by our Chief Medical Officer.